Publications
Publications, Books, Book Chapters and Reviews by Prof. Marcus Maurer, MD
Use: Start with an overview of all publications. Use tag links to list selected documents or to list an entire category, e.g. Original Work, Books, Book Chapters, Reviews. If you know what you are looking for, enter this term in the search field.
- Order by:
- Title
- Date added
- Download count
- [o.394] Anaphylaxis to mepolizumab and omalizumab in a single patient – is polysorbate the culprit? (2)
- [r.161] Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of Ärzteverband Deutscher Allergologen (AeDA), Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI), Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA), Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI), Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI), Österreichische Gesellschaft für Pneumologie (ÖGP) in co-operation with the German, Austrian, and Swiss ARIA groups, and the European Academy of Allergy and Clinical Immunology (EAACI) (4)
- [o.412] Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria – a systematic review for the EAACI biologicals guidelines (1)
- [r.162] Total IgE as marker in chronic spontaneous urticaria (2)
- [o.409] Anwendung von Biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen Covid-19-Pandemie (0)
- [o.410] Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both (1)
- [o.414] Autoimmune diseases are linked to type IIb autoimmune chronic spontaneous urticaria (3)
- [o.415] The global impact of the COVID-19 pandemic on the management and course of chronic urticaria (0)
- [o.417] Case Report: Omalizumab for chronic spontaneous urticaria in pregnancy (0)
- [o.419] Expert consensus on practical aspects in the treatment of chronic urticaria (1)
- [r.169] Differences and similarities in the mechanisms and clinical expression of bradykinin-mediated vs. mast cell-mediated angioedema (3)
- [o.421] Omalizumab in chronic inducible urticaria: a real-life study of efficacy, safety, predictors of treatment outcome and time to response (2)
- [o.423] Omalizumab in children and adolescents with chronic urticaria: a 16 week real-world study (0)
- [o.427] Omalizumab is effective in patients with chronic spontaneous urticaria plus multiple chronic inducible urticaria (2)
- [r.171] What is the contribution of IgE to nasal polyposis? (0)
- [r.173] Expert consensus on the use of omalizumab in chronic urticaria in China (224)
- [bc.42] Omalizumab in the treatment of urticaria (125)
- « Previous
- 1
- 2
(Last update: 12.2023)
Number of original publications in peer-reviewed journals: | 580 |
Number of reviews in peer-reviewed journals: | 210 |
Number of publications (original work and reviews) in peer-reviewed journals: | 790 |
Cumulative IF for original publications in peer-reviewed journals: | 4196.39 |
Cumulative IF for reviews in peer-reviewed journals: | 1409.32 |
Cumulative IF of publications (original work & reviews) in peer-reviewed journals: | 5605.71 |
Total number of citations: 36,836, h-index: 99 (Web of Science December 2023) | 36836 |
Download-Information
To be able to download the offered contents, you have to login. If you do not know the login, please write me your request.